Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 783

    1.

    Intravitreal triamcinolone versus laser photocoagulation for persistent diabetic macular oedema.

    Ockrim ZK, Sivaprasad S, Falk S, Roghani S, Bunce C, Gregor Z, Hykin P.

    Br J Ophthalmol. 2008 Jun;92(6):795-9. Epub 2008 Apr 17.PMID: 18420749 [PubMed - indexed for MEDLINE]Related articles

    2.

    Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.

    Lam DS, Chan CK, Mohamed S, Lai TY, Lee VY, Liu DT, Li KK, Li PS, Shanmugam MP.

    Ophthalmology. 2007 Dec;114(12):2162-7. Epub 2007 Apr 25.PMID: 17459479 [PubMed - indexed for MEDLINE]Related articles

    3.

    Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.

    Avitabile T, Longo A, Reibaldi A.

    Am J Ophthalmol. 2005 Oct;140(4):695-702.PMID: 16226521 [PubMed - indexed for MEDLINE]Related articles

    4.

    Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.

    Batioğlu F, Ozmert E, Parmak N, Celik S.

    Int Ophthalmol. 2007 Oct;27(5):299-306. Epub 2007 Apr 24.PMID: 17453151 [PubMed - indexed for MEDLINE]Related articles

    5.

    A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.

    Diabetic Retinopathy Clinical Research Network.

    Ophthalmology. 2008 Sep;115(9):1447-9, 1449.e1-10. Epub 2008 Jul 26.PMID: 18662829 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.

    Soheilian M, Ramezani A, Bijanzadeh B, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Tabatabaei H, Peyman GA.

    Retina. 2007 Nov-Dec;27(9):1187-95.PMID: 18046223 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Macular thickness analysis by optic coherence tomography in refractory diabetic macular edema treated with intravitreous triamcinolone]

    Pinheiro A, Serracarbassa PD, Maia OO Jr, Takahashi WY.

    Arq Bras Oftalmol. 2007 Sep-Oct;70(5):784-9. Portuguese. PMID: 18157302 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.

    Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S.

    Br J Ophthalmol. 2004 Sep;88(9):1131-6.PMID: 15317702 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.

    Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M.

    Ophthalmology. 2006 Sep;113(9):1533-8. Epub 2006 Jul 7.PMID: 16828501 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intravitreal triamcinolone for refractory diabetic macular edema.

    Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C.

    Ophthalmology. 2002 May;109(5):920-7.PMID: 11986098 [PubMed - indexed for MEDLINE]Related articles

    12.

    Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.

    Sivaprasad S, Ockrim Z, Massaoutis P, Ikeji F, Hykin PG, Gregor ZJ.

    Retina. 2008 Nov-Dec;28(10):1435-42.PMID: 18628722 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).

    Paccola L, Costa RA, Folgosa MS, Barbosa JC, Scott IU, Jorge R.

    Br J Ophthalmol. 2008 Jan;92(1):76-80. Epub 2007 Oct 26.PMID: 17965109 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation.

    Negi AK, Vernon SA, Lim CS, Owen-Armstrong K.

    Eye (Lond). 2005 Jul;19(7):747-51.PMID: 15359268 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Triamcinolone in the treatment of the diabetic macular edema--one-year results]

    Dusová J, Studnicka J, Rencová E, Korda V, Hejcmanová D.

    Cesk Slov Oftalmol. 2008 Jul;64(4):149-52. Czech. PMID: 18780654 [PubMed - indexed for MEDLINE]Related articles

    16.

    Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.

    Ozdek S, Bahçeci UA, Gürelik G, Hasanreisoğlu B.

    J Diabetes Complications. 2006 Jul-Aug;20(4):246-51.PMID: 16798476 [PubMed - indexed for MEDLINE]Related articles

    17.

    A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema.

    Lam DS, Chan CK, Mohamed S, Lai TY, Li KK, Li PS, Tsang CW, Chan WM, Shanmugam MP.

    Br J Ophthalmol. 2007 Feb;91(2):199-203. Epub 2006 Sep 14.PMID: 16973659 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.

    Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A.

    Ophthalmology. 2004 Feb;111(2):218-24; discussion 224-5.PMID: 15019365 [PubMed - indexed for MEDLINE]Related articles

    19.

    Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema.

    Faghihi H, Roohipoor R, Mohammadi SF, Hojat-Jalali K, Mirshahi A, Lashay A, Piri N, Faghihi Sh.

    Eur J Ophthalmol. 2008 Nov-Dec;18(6):941-8.PMID: 18988166 [PubMed - indexed for MEDLINE]Related articles

    20.

    Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.

    Writing Committee for the Diabetic Retinopathy Clinical Research Network, Fong DS, Strauber SF, Aiello LP, Beck RW, Callanan DG, Danis RP, Davis MD, Feman SS, Ferris F, Friedman SM, Garcia CA, Glassman AR, Han DP, Le D, Kollman C, Lauer AK, Recchia FM, Solomon SD.

    Arch Ophthalmol. 2007 Apr;125(4):469-80.PMID: 17420366 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data